Rosmarinic acid induces apoptosis of activated t cells from rheumatoid arthritis patients via mitochondrial pathway

被引:67
作者
Hur, Yun-Gyoung
Suh, Chang-Hee
Kim, Sungjoo
Won, Jonghwa
机构
[1] Mogam Biotechnol Res Inst, Div Immune Regulat, Yongin 446799, Gyounggi Do, South Korea
[2] Ajou Univ, Sch Med, Ctr Arthritis, Suwon 441749, Gyounggi Do, South Korea
关键词
T cell; rheumatoid arthritis; rosmarinic acid; apoptosis;
D O I
10.1007/s10875-006-9057-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
T cells play an important role in the initiation and the progression of rheumatoid arthritis (RA) and depletion of potentially pathogenic T cells was suggested as an important therapeutic protocol. We determined if rosmarinic acid (RosA), known as a secondary metabolite from herbal plants, had apoptotic activity toward T cells from RA patients and further verified target T-cell subsets. CD3(+)CD25(+) activated T-cell subsets from most of the RA patients displayed significantly higher apoptosis rates than did the PBMCs and total CD3(+) T cells. Furthermore, activated and effector CD4(+) T cells, including CD4(+)CD25(+) and CD4(+)CD45RO(+) T cells, had a tendency of being more susceptible to RosA-induced apoptosis than that of resting and naive T-cell subsets. RosA induced the release of cytochrome c from mitochondria and the blockage of mitochondrial depolarization inhibited apoptosis. Taken together, these results suggest that RosA induces apoptosis of activated T-cell subsets from RA patients via a mitochondrial pathway.
引用
收藏
页码:36 / 45
页数:10
相关论文
共 58 条
[1]
CD28-mediated co-stimulation: A quantitative support for TCR signalling [J].
Acuto, O ;
Michel, F .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (12) :939-951
[2]
Al-Sereiti M. R., 1999, Indian Journal of Experimental Biology, V37, P124
[3]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[4]
Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis [J].
Balandina, A ;
Lécart, S ;
Dartevelle, P ;
Saoudi, A ;
Berrih-Aknin, S .
BLOOD, 2005, 105 (02) :735-741
[5]
Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO
[6]
2-E
[7]
Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients - Cross-talk between T cells and synovial fibroblasts [J].
Cho, ML ;
Yoon, CH ;
Hwang, SY ;
Park, MK ;
Min, SY ;
Lee, SH ;
Park, SH ;
Kim, HY .
ARTHRITIS AND RHEUMATISM, 2004, 50 (03) :776-784
[8]
Chou CT, 2001, J PATHOL, V193, P110, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH746>3.0.CO
[9]
2-K
[10]
Choy EHS, 1998, BRIT J RHEUMATOL, V37, P484